書籍詳細

ステロイド治療薬 (副腎皮質ステロイド)

P.133 掲載の参考文献

• 1) Carr, B. R. et al. :The role of calcium in steroidogenesis in fetal zone cells of the human fetal adrenal gland. J Clin Endocrinol & Metab 63:913, 1986.
  pubmed

• 2) Miyamori, I. et al. :Role of intestinal bacteria in the metabolism of aldosterone in man. Hormone Res 29:147, 1988.

• 3) Gustafsson, J-A et al. :Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocrin Rev 8:185, 1987.

• 4) Arriza, J. L. et al. :Cloning of human mineralocorticoid receptor complementary DNA:Structural and functional kinship with the glucocorticoid receptor. Science 237:268, 1987.
  pubmed

• 5) 竹田 亮祐:フロリネフFlorinef(R)臨床水電解質3:503, 1985.

• 6) Frey, F. J. :Kinetics and dynamics of prednisolone. Endocrine Rev 8:453, 1987.

• 7) Stuck, A. E. et al. :Kinetics of prednisolone and endogenous cortisol suppression in the elderly. Clin Pharm Therap 43:352, 1988.

• 8) Milsap, R. L. et al. :Prednisolone disposition in obese men. Clin Pharm Therap 36: 824, 1984.
  pubmed

• 9) 竹田亮祐ほか:ステロイドホルモンの分析:最近の知見 -高速液体クロマトグラフィー(HPLC) 日本臨牀42:2530, 1984.

• 10) Kyriazopoulou, V. et al. :Rifampcin-induced adrenal crisis in Addisonian patients receiving corticosteroid replacement therapy. J Clin Endocrinol & Metab 59: 1204, 1984.

• 11) 小田 実ほか:リファンピシン併用によりステロイド効果の減弱が認められたネフローゼ症候群の1例. 日腎誌30:221, 1988.

• 12) Kandroatas, R. J. et al. : Ketoconazole effects on methylprednisolone disposition and their joint suppuression of endogenous cortisol. Clin Pharmacol Therap 42:465, 1987.

• 13) 竹田 亮祐ほか. ステロイド ホルモン. 医学と薬学9. 1419, 1983.

• 14) Miyachi, T. et al. :Blood levels of synthetic glucocorticoids after administration by various routes. J Endocrinol 82 :149, 1979.

• 15) Baylis, E. M. et al. :High dose intra-venous methylprednisolone"pulse"therapy in patiennts with rheumatoid disease. Eur J Clin Pharmacol 21:385, 1982.

• 16) Armstrong, R. D. et al. :Serum methylprednisolone levels following intra-art icular injection of methylprednisolone acetate. Ann Rheumat Dis 40:571, 1981.

• 17) 五十嵐良雄ほか:塩喪失型先天性副腎過形成におけるフロニネフ〔Florinef・Fludrocortisone acetate 日本スクイブ〕の暫定使用基準 厚生省特定疾患「副腎ホルモン産生異常症」調査研究班 昭和62年度研究報告書(班長 竹田 亮祐)63頁, 1988.

• 18) Scott, R. S. et al. :Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin Endocrinol 9:571, 1978.
  pubmed

• 19) 中村 毅:静注用Dexamethasone製剤の生体内代謝および下垂体・副腎皮質系への効果について -エステルによる差について. 臨床薬理12:1, 1981.

• 20) 志水 正敏:慢性関節リウマチ. 綜合臨牀 36:1764, 1987.

• 21) Iannuzzi, L. :Oral steroids in rheumatoid arthritis. Postgrad Med 82:295, 1987.
  pubmed

• 22) Ohira, T. et al. :Hydroxyapatite deposition in articular cartilage by intraarticular injections of methylprednisolone. J Bone & Joint Surg 68-A:509, 1986.
  pubmed

• 23) Bird, H. A. et al. :An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434, 1979.
  pubmed

• 24) William, T. et al. :Polymyalgia rheumatica-Duration of therapy and long-term outcome. Am J Med 79:309, 1985.

• 25) 本間 光夫ほか:膠原病の副腎皮質ステロイド療法 内科 55:417, 1985.

• 26) Jamiesen, T. :Corticosteroids for rheumatic disease. Postgrand Med 79:239, 1986.

• 27) Yanagisawa, T. et al. :Methylprednisolone pulse therapy in dermatomyositis. Dermatologica 167:47, 1983.
  pubmed

• 28) Wolff, S. M. et al. :Wegner's granulomatosis. Ann Intern Med 81:513, 1974.

• 29) Harrison, H. Let al. :Bolus corticosteroids and cyclophosphamide for initial treatment of Wegner's granulomatosis. JAMA 244:1599, 1980.

• 30) Fauci, A. S. et al. :Wegener's granulomatosis. Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76, 1983.
  pubmed

• 31) Patterson, M . H. et al. :Periarteritis nodosa-A remission achieved with combined prednisone and azathioprine therapy. Am J Dis Child 121:424, 1974.

• 32) Leib, E. S. et al. :Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 67:941, 1974.

• 33) Lederle, F. A. et aL:Tapering of corticosteroid therapy following exacerbation of asthma. A randomized double-blind, placebo-controlled trial. Arch Intern Med 147:2201, 1974.

• 34) Lasser, E. C. et al. :Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. NEJM 317:845, 1987.
  pubmed

• 35) Runyan B. A. :Exquisite sensitivity to small decrements in corticosteroid dose in autoimmune chronic active hepatitis. J Clin Gastroent 9:541, 1987.

• 36) International Study of Kidney Disease in Children:The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561, 1981.

• 37) Collaborative Study of the Adult Idiopathic Nephrotic Syndrome:A controlled study of short term prednisone treatment in adults with membranous nephropathy. NEJM 301:1301, 1979.
  pubmed

• 38) McEnery, P. T. et al. :Membrano-proliferative glomerulonephritis improved survival with alternate day prednisolone therapy. Clin Nephrol 13:117, 1980.

• 39) Kobayashi, Y. et al. :Steroid therapy in IgA nephropathy:A prospective pilot study in moderate proteinuric cases. Quart J Med 61:935, 1986.
  pubmed

• 40) Lai, K. N. et al. :Corticosteroid therapy in IgA nephropathy with nephrotic syndrome:A long term controlled trial. Clin Nephrol 26:4, 1986.
  pubmed

• 41) Simons, E. R. et al. :Clinical conferences at the Johns Hopkins Hospital. Johns Hoskins Med J 148:179, 1981.

• 42) Spratling, L. et al. :Daily vs alternate day prednisone therapy for stage II sarcoidosis. Chest 88:687, 1985.
  pubmed

• 43) Harkleroad, L. E. et al. :Pulmonary sarcoidosis. Long-term follow-up of the effects of steroid therapy. Chest 82:84, 1982.
  pubmed

• 44) Eule, H. et al. :The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Ann NY Acad Sci 465:695, 1986.

• 45) Zaki, M. et al. :Corticosteroid therapy in sarcoidosis -A five-year, controlled follow-up study. New York State J Med 87:496, 1987.

• 46) Cathcart, E. S. et al. :Benefical effects of methylprednisolone pulse therapy in diffuse proliferative lupus nephritis. Lancet 163: , 1976.

• 47) Eyanson, S. :Methylprednisolone pulse therapy for nonrenal lupus erythematosus. Ann Rheum Dis 39:377, 1980.
  pubmed

• 48) Isenberg, D. A. et al. :Methylprednisolone pulse therapy in the treatment of systemic lupus erythematosus. Ann Rheum Dis 41:347, 1982.
  pubmed

• 49) Liebling, M. R. et al. :Pulse methylprednisolone in rheumatoid arthritis. Ann Intern Med 94；21, 1981.
  pubmed

• 50) Foster, P. J. G. et al:High dose intravenous methylprednisolone in rheumatoid arithritis. Ann Rheum Dis : , 1981.

• 51) Smith, M. et al. :Pulse steroid therapy in rheumatoid arthritis:Can equivalent doses of aral prednisolone give similar clinical result to intravenous methlprednisolone? Ann Rheum Dis 47:28, 1988.

• 52) Steven, I. et al. :Treatment of temporal arthritis with ocular involvement. Am J Med 80:143, 1986.

• 53) Durelli, et al. :High dose intravenous methylprednisolone in the treatment of multiple sclerosis. Neurology 36:238, 1986.
  pubmed

• 54) Arsura, E. et al. :High dose intravenous methylprednisolone in myasthenia gravis. Arch Neurol 42:1149, 1985.
  pubmed

• 55) 森 悦朗ほか:Acute Guillain-Barre syndromeに対する血漿交換療法の有用性 -ステロイドパルス療法との比較. 臨床神経学28:196, 1988.

• 56) Petty, T. L. et al. :Another look at ARDS. Chest 82:98, 1982.

• 57) 平田 昌義ほか:ARDSを呈したステロイドパルス療法により軽快したオウム病の1例. 呼吸と循環 36:893, 1988.

• 58) Littenberg, B. et al. :A controlled trial of methylprednisolone in the emergency treatment of acute asthma. NEJM 150:152, 1986.

• 59) Ratto, D. et al. :Are intravenous corticosteroids required in status asthmatics? JAMA 260:527, 1988.
  pubmed

• 60) Ohta, A. :Pulse metyhylprednisolone therapy in idiopathic thrombocytopenic purpura. Acta haematol 70:345, 1983.

• 61) Bacigalupo, A. et al. :Bolus methylprednisolone in severe aplastic anemia. NEJM 300:501, 1979.
  pubmed

• 62) 内山 伸治ほか:風疹抗体価上昇, 抗甲状腺抗体免疫複合体陽性を呈した知覚型急性多発根神経炎. 神経内科26:280, 1987.

• 63) Sallivan, J. N. :Saturday conference:Steroid withdrawal syndromes. South Med J 75:726, 1982.

• 64) Liddle, G. W. :The adrenals, part I:the adrenal cortex, Williams, R. H. (ed. ) Textbook of Endocrinoligy Philadelphia W. B. Saunders Co. 6th Ed. 1981, p275.

• 65) Ohman, E. M. et al. :Adrenal suppression following low-dose topical clobetasol propionate. J Roy Soc Med 80:422, 1987.
  pubmed

• 66) Takeda, R. :Side effect of corticosteroid therapy and countermeasures. Asian Med J 30:42, 1987.

• 67) Erenstam, E. et al. :The acute effect of high dose corticosteroid treatment on serum osteoclacin. Metabolism 37:141, 1988.

• 68) Pocock, N. A. et al. :Recovery from steroid-induced osteoporosis. Ann Intern Med 107:319, 1987.
  pubmed

• 69) Garrett, R. et al. :Comparisons of intravenous methylprednisolone pulse therapy. Arth Rheum 23:677, 1980.